Recombinant Adeno-associated virus 2 (ATCC^® VR-1616^™)

Classification: Parvoviridae, Dependovirus, Adeno-associated virus-2 / Product Format: frozen

Recombinant Adeno-associated virus 2 ATCC^® VR-1616^™

frozen

For-Profit: $354.00 Non-Profit: $295.00

Qty:

Permits and Restrictions	View Permits
Classification	Parvoviridae, Dependovirus, Adeno-associated virus-2
Agent	Recombinant Adeno-associated virus 2
Strain	Recombinant Adeno-associated Virus 2 Reference Standard Stock (rAAV2 RSS)
Biosafety Level	2
Product Format	frozen
Storage Conditions	-70°C or colder

Comments	For additional information on handling the Recombinant Adeno-associated Virus 2 Reference Standard Stock, view the AAVRSWG Handling Guide located on the ATCC website at www.atcc.org.

Growth Conditions	Temperature: 37°C

Name of Depositor	Adeno-associated Virus Reference Standard Working Group (AAVRSWG)
References	Moullier P, Snyder, RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol. Ther. 16:1185-1188, 2008. Potter M, et al. Manufacture and stability study of the recombinant adeno-associated virus serotype 2 vector reference standard. BioProcessing Journal 7:8-14, 2008. Burger C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Molecular Therapy : 10(2):302-17, 2004 PubMed: 15294177 Flotte TR, e al. Utility of a recombinant adeno-associated viral vector reference standard. BioProcessing J. 1: 75, 2002. Chadeuf G, et al. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. J. Gene Med. 2(4):260-268, 2000. PubMed: 10953917. Grimm D, et al. Novel tools for production and purification of recombinant adeno-associated virus vectors. Human Gene Therapy 9: 2745-2760, 1998.

Name of Depositor

Adeno-associated Virus Reference Standard Working Group (AAVRSWG)

References

Moullier P, Snyder, RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol. Ther. 16:1185-1188, 2008.

Potter M, et al. Manufacture and stability study of the recombinant adeno-associated virus serotype 2 vector reference standard. BioProcessing Journal 7:8-14, 2008.

Burger C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Molecular Therapy : 10(2):302-17, 2004 PubMed: 15294177

Flotte TR, e al. Utility of a recombinant adeno-associated viral vector reference standard. BioProcessing J. 1: 75, 2002.

Chadeuf G, et al. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. J. Gene Med. 2(4):260-268, 2000. PubMed: 10953917.

Grimm D, et al. Novel tools for production and purification of recombinant adeno-associated virus vectors. Human Gene Therapy 9: 2745-2760, 1998.

Permits	These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation	Product Sheet Certificate of Analysis MSDS
Other Documentation	AAVRSWG Handling Guide

Recombinant Adeno-associated virus 2 (ATCC® VR-1616™)

Share this product

Your session will expire in

Recombinant Adeno-associated virus 2 (ATCC^® VR-1616^™)